Cargando…
Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
INTRODUCTION: Studies suggest associations between proton pump inhibitors (PPIs) and dementia risk; however, many neither considered histamine‐2 receptor antagonists (H2RAs) nor baseline cognitive status. METHODS: Participants (National Alzheimer's Coordinating Center Database; 2005–2021) using...
Autores principales: | Wu, Che‐Yuan, Xiong, Lisa Y., Ouk, Michael, Rabin, Jennifer S., Herrmann, Nathan, Lanctôt, Krista L., Kapral, Moira K., Law, Marcus, Cogo‐Moreira, Hugo, Edwards, Jodi D., Swardfager, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829893/ https://www.ncbi.nlm.nih.gov/pubmed/35169610 http://dx.doi.org/10.1002/trc2.12243 |
Ejemplares similares
-
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Xiong, Lisa Y., et al.
Publicado: (2021) -
Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status
por: Wu, Che‐Yuan, et al.
Publicado: (2020) -
The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status
por: Ouk, Michael, et al.
Publicado: (2021) -
A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease
por: Bawa, Kritleen K., et al.
Publicado: (2020) -
State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's disease
por: Cogo‐Moreira, Hugo, et al.
Publicado: (2023)